Previous Close | 45.41 |
1-Year Change | -29.77% |
6-Months Change | -9.88% |
3-Months Change | 12.48% |
Moving Avg (50d) | 50.154 |
Moving Avg (200d) | 50.068 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 2.07B |
Beta (3-Years) | 1.37 |
Revenue Growth (ttm) | 3.36% |
Net Profit Margin (ttm) | -24.91% |
Return On Assets (ttm) | -7.93% |
EPS (ttm) | -3.07 |
PE Ratio (ttm) | -14.79 |
Dividend Yield | % |
Asset Description: | Azenta, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2025-01-06 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
44.502 | 43.139 | 42.231 | 40.869 | 38.598 | 36.328 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Supplies |
Country: | United States |
Azenta was founded in 1978, and is based in Chelmsford, Massachusetts, United States. The company is a provider of life sciences services including genomics, cryogenic storage, automation, and informatics. Wikipedia